Shares of Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) rose sharply during Tuesday’s session after the company released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of Developmental and Epileptic Encephalopathies (DEEs). Longboard Pharmaceuticals shares jumped 199.7% to $18.07 on Tuesday. Here are some other stocks moving in today’s mid-day session. GainersAkso Health Group (NASDAQ: AHG) surged 85% to $1.2946.Polished.com Inc. (NYSE: POL) gained 45% to $8.77.Dogness (International) Corporation (NASDAQ: DOGZ) jumped …

Read More